ProMetic to develop affinity resin product, related manufacturing process
Under the agreement, ProMetic will receive $1.4m and the client will be provided with a biosimilar product. PBL chief executive officer Steve Burton said the company’s technology allows
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.